We found that aberrations in the lowest malignancy type (DA) affects AKT1, AKT2 and GSK3β genes with a similar frequency, while a different set of genes (CHUK, EGFR, PIK3AP1, and PTEN) were highly affected in GBM (Table 2). This evidence concerns the gene AKT1 and glioblastoma.